• Blog - Diseases & Conditions

    NSAIDs and Anticoagulants: Bleeding Risks

    Introduction Nonsteroidal anti-inflammatory drugs (NSAIDs) and anticoagulants are two classes of medications widely used across various medical disciplines. NSAIDs, such as ibuprofen and naproxen, are commonly employed to relieve pain, inflammation, and fever. On the other hand, anticoagulants, including warfarin, rivaroxaban, and apixaban, are prescribed to prevent or treat thromboembolic events such as deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke in atrial fibrillation. While each medication serves a vital therapeutic role, their concurrent use can significantly elevate the risk of bleeding. This concern becomes particularly relevant in populations such as the elderly, individuals with chronic pain conditions, and…

  • Blog - Prevention & Wellness - Resources & Tools

    NSAIDs and Anticoagulants: Bleeding Risks

    Introduction Nonsteroidal anti-inflammatory drugs (NSAIDs) and anticoagulants are two commonly prescribed medication classes used to manage pain, inflammation, and prevent or treat blood clots. While both are effective within their therapeutic areas, their concurrent use poses significant clinical risks—particularly an increased risk of bleeding. Understanding the pharmacological interactions and implementing vigilant management strategies is critical to safeguarding patient health. Mechanism of Interaction The mechanism by which NSAIDs and anticoagulants interact is primarily pharmacodynamic in nature. NSAIDs, such as ibuprofen, naproxen, and diclofenac, inhibit cyclooxygenase (COX) enzymes—especially COX-1—which reduces the production of prostaglandins and thromboxane A2. Thromboxane A2 is vital for…